Tadaaki Yamada

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +17

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Wei Wang, Qi Li, Tadaaki Yamada et al. · Clinical Cancer Research · 2009 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

Seiji Yano, Tadaaki Yamada, Shinji Takeuchi et al. · Journal of Thoracic Oncology · 2011 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

EGFR-TKI Resistance Due to <i>BIM</i> Polymorphism Can Be Circumvented in Combination with HDAC Inhibition

Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada et al. · Cancer Research · 2013 · 157 citations · Full text

Medicine, Oncology, Pharmacology +17

Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials

M. Hale, James Wild, Jyotsna Reddy et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +12